Global Alinia (nitazoxanide) Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Alinia (nitazoxanide) Market
Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

Due to the COVID-19 pandemic, the global Alinia (nitazoxanide) market size is estimated to be worth US$ 185.9 million in 2022 and is forecast to a readjusted size of US$ 225.9 million by 2028 with a CAGR of 3.3% during the review period. Fully considering the economic change by this health crisis, Tablets accounting for % of the Alinia (nitazoxanide) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Retail Pharmacy segment is altered to an % CAGR throughout this forecast period.

The key players of Alinia (nitazoxanide) include Romark Laboratories, Chugai Pharmaceutical, Lupin etc. The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market. Asia-Pacific is the largest consumer market of Alinia (nitazoxanide) accounting for about 45% followed by South America and Europe. In terms of Type, Tablets is the largest segment, with a share about 99%. And in terms of Application, the largest application is Hospital followed by Retail Pharmacy.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Tablets

Oral Suspension

Segment by Application

Retail Pharmacy

Hospital

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Alinia (nitazoxanide) market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Romark Laboratories

Chugai Pharmaceutical

Lupin

TABLE OF CONTENT

1 Study Coverage
1.1 Alinia (nitazoxanide) Product Introduction

1.2 Market by Type

1.2.1 Global Alinia (nitazoxanide) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Tablets

1.2.3 Oral Suspension

1.3 Market by Application

1.3.1 Global Alinia (nitazoxanide) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Retail Pharmacy

1.3.3 Hospital

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Alinia (nitazoxanide) Sales Estimates and Forecasts 2017-2028

2.2 Global Alinia (nitazoxanide) Revenue Estimates and Forecasts 2017-2028

2.3 Global Alinia (nitazoxanide) Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Alinia (nitazoxanide) Sales by Region

2.4.1 Global Alinia (nitazoxanide) Sales by Region (2017-2022)

2.4.2 Global Sales Alinia (nitazoxanide) by Region (2023-2028)

2.5 Global Alinia (nitazoxanide) Revenue by Region

2.5.1 Global Alinia (nitazoxanide) Revenue by Region (2017-2022)

2.5.2 Global Alinia (nitazoxanide) Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Alinia (nitazoxanide) Sales by Manufacturers

3.1.1 Global Top Alinia (nitazoxanide) Manufacturers by Sales (2017-2022)

3.1.2 Global Alinia (nitazoxanide) Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alinia (nitazoxanide) in 2021

3.2 Global Alinia (nitazoxanide) Revenue by Manufacturers

3.2.1 Global Alinia (nitazoxanide) Revenue by Manufacturers (2017-2022)

3.2.2 Global Alinia (nitazoxanide) Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Alinia (nitazoxanide) Revenue in 2021

3.3 Global Alinia (nitazoxanide) Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Alinia (nitazoxanide) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Alinia (nitazoxanide) Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Alinia (nitazoxanide) Sales by Type

4.1.1 Global Alinia (nitazoxanide) Historical Sales by Type (2017-2022)

4.1.2 Global Alinia (nitazoxanide) Forecasted Sales by Type (2023-2028)

4.1.3 Global Alinia (nitazoxanide) Sales Market Share by Type (2017-2028)

4.2 Global Alinia (nitazoxanide) Revenue by Type

4.2.1 Global Alinia (nitazoxanide) Historical Revenue by Type (2017-2022)

4.2.2 Global Alinia (nitazoxanide) Forecasted Revenue by Type (2023-2028)

4.2.3 Global Alinia (nitazoxanide) Revenue Market Share by Type (2017-2028)

4.3 Global Alinia (nitazoxanide) Price by Type

4.3.1 Global Alinia (nitazoxanide) Price by Type (2017-2022)

4.3.2 Global Alinia (nitazoxanide) Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Alinia (nitazoxanide) Sales by Application

5.1.1 Global Alinia (nitazoxanide) Historical Sales by Application (2017-2022)

5.1.2 Global Alinia (nitazoxanide) Forecasted Sales by Application (2023-2028)

5.1.3 Global Alinia (nitazoxanide) Sales Market Share by Application (2017-2028)

5.2 Global Alinia (nitazoxanide) Revenue by Application

5.2.1 Global Alinia (nitazoxanide) Historical Revenue by Application (2017-2022)

5.2.2 Global Alinia (nitazoxanide) Forecasted Revenue by Application (2023-2028)

5.2.3 Global Alinia (nitazoxanide) Revenue Market Share by Application (2017-2028)

5.3 Global Alinia (nitazoxanide) Price by Application

5.3.1 Global Alinia (nitazoxanide) Price by Application (2017-2022)

5.3.2 Global Alinia (nitazoxanide) Price Forecast by Application (2023-2028)

6 North America

6.1 North America Alinia (nitazoxanide) Market Size by Type

6.1.1 North America Alinia (nitazoxanide) Sales by Type (2017-2028)

6.1.2 North America Alinia (nitazoxanide) Revenue by Type (2017-2028)

6.2 North America Alinia (nitazoxanide) Market Size by Application

6.2.1 North America Alinia (nitazoxanide) Sales by Application (2017-2028)

6.2.2 North America Alinia (nitazoxanide) Revenue by Application (2017-2028)

6.3 North America Alinia (nitazoxanide) Market Size by Country

6.3.1 North America Alinia (nitazoxanide) Sales by Country (2017-2028)

6.3.2 North America Alinia (nitazoxanide) Revenue by Country (2017-2028)

6.3.3 United States

6.3.4 Canada

7 Europe

7.1 Europe Alinia (nitazoxanide) Market Size by Type

7.1.1 Europe Alinia (nitazoxanide) Sales by Type (2017-2028)

7.1.2 Europe Alinia (nitazoxanide) Revenue by Type (2017-2028)

7.2 Europe Alinia (nitazoxanide) Market Size by Application

7.2.1 Europe Alinia (nitazoxanide) Sales by Application (2017-2028)

7.2.2 Europe Alinia (nitazoxanide) Revenue by Application (2017-2028)

7.3 Europe Alinia (nitazoxanide) Market Size by Country

7.3.1 Europe Alinia (nitazoxanide) Sales by Country (2017-2028)

7.3.2 Europe Alinia (nitazoxanide) Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Alinia (nitazoxanide) Market Size by Type

8.1.1 Asia Pacific Alinia (nitazoxanide) Sales by Type (2017-2028)

8.1.2 Asia Pacific Alinia (nitazoxanide) Revenue by Type (2017-2028)

8.2 Asia Pacific Alinia (nitazoxanide) Market Size by Application

8.2.1 Asia Pacific Alinia (nitazoxanide) Sales by Application (2017-2028)

8.2.2 Asia Pacific Alinia (nitazoxanide) Revenue by Application (2017-2028)

8.3 Asia Pacific Alinia (nitazoxanide) Market Size by Region

8.3.1 Asia Pacific Alinia (nitazoxanide) Sales by Region (2017-2028)

8.3.2 Asia Pacific Alinia (nitazoxanide) Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Alinia (nitazoxanide) Market Size by Type

9.1.1 Latin America Alinia (nitazoxanide) Sales by Type (2017-2028)

9.1.2 Latin America Alinia (nitazoxanide) Revenue by Type (2017-2028)

9.2 Latin America Alinia (nitazoxanide) Market Size by Application

9.2.1 Latin America Alinia (nitazoxanide) Sales by Application (2017-2028)

9.2.2 Latin America Alinia (nitazoxanide) Revenue by Application (2017-2028)

9.3 Latin America Alinia (nitazoxanide) Market Size by Country

9.3.1 Latin America Alinia (nitazoxanide) Sales by Country (2017-2028)

9.3.2 Latin America Alinia (nitazoxanide) Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Alinia (nitazoxanide) Market Size by Type

10.1.1 Middle East and Africa Alinia (nitazoxanide) Sales by Type (2017-2028)

10.1.2 Middle East and Africa Alinia (nitazoxanide) Revenue by Type (2017-2028)

10.2 Middle East and Africa Alinia (nitazoxanide) Market Size by Application

10.2.1 Middle East and Africa Alinia (nitazoxanide) Sales by Application (2017-2028)

10.2.2 Middle East and Africa Alinia (nitazoxanide) Revenue by Application (2017-2028)

10.3 Middle East and Africa Alinia (nitazoxanide) Market Size by Country

10.3.1 Middle East and Africa Alinia (nitazoxanide) Sales by Country (2017-2028)

10.3.2 Middle East and Africa Alinia (nitazoxanide) Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Romark Laboratories

11.1.1 Romark Laboratories Corporation Information

11.1.2 Romark Laboratories Overview

11.1.3 Romark Laboratories Alinia (nitazoxanide) Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Romark Laboratories Alinia (nitazoxanide) Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Romark Laboratories Recent Developments

11.2 Chugai Pharmaceutical

11.2.1 Chugai Pharmaceutical Corporation Information

11.2.2 Chugai Pharmaceutical Overview

11.2.3 Chugai Pharmaceutical Alinia (nitazoxanide) Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Chugai Pharmaceutical Alinia (nitazoxanide) Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Chugai Pharmaceutical Recent Developments

11.3 Lupin

11.3.1 Lupin Corporation Information

11.3.2 Lupin Overview

11.3.3 Lupin Alinia (nitazoxanide) Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Lupin Alinia (nitazoxanide) Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Lupin Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Alinia (nitazoxanide) Industry Chain Analysis

12.2 Alinia (nitazoxanide) Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Alinia (nitazoxanide) Production Mode & Process

12.4 Alinia (nitazoxanide) Sales and Marketing

12.4.1 Alinia (nitazoxanide) Sales Channels

12.4.2 Alinia (nitazoxanide) Distributors

12.5 Alinia (nitazoxanide) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Alinia (nitazoxanide) Industry Trends

13.2 Alinia (nitazoxanide) Market Drivers

13.3 Alinia (nitazoxanide) Market Challenges

13.4 Alinia (nitazoxanide) Market Restraints

14 Key Findings in The Global Alinia (nitazoxanide) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample